214 related articles for article (PubMed ID: 10227615)
1. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
Elterman RD; Glauser TA; Wyllie E; Reife R; Wu SC; Pledger G
Neurology; 1999 Apr; 52(7):1338-44. PubMed ID: 10227615
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
[TBL] [Abstract][Full Text] [Related]
4. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
[TBL] [Abstract][Full Text] [Related]
5. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
[TBL] [Abstract][Full Text] [Related]
6. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
Guberman A; Neto W; Gassmann-Mayer C;
Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
[TBL] [Abstract][Full Text] [Related]
7. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
Novotny E; Renfroe B; Yardi N; Nordli D; Ness S; Wang S; Weber T; Kurland CL; Yuen E; Eerdekens M; Venkatraman L; Nye JS; Ford L
Neurology; 2010 Mar; 74(9):714-20. PubMed ID: 20089937
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group.
Sachdeo RC; Glauser TA; Ritter F; Reife R; Lim P; Pledger G
Neurology; 1999 Jun; 52(9):1882-7. PubMed ID: 10371538
[TBL] [Abstract][Full Text] [Related]
11. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
[TBL] [Abstract][Full Text] [Related]
12. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures.
Chung SS; Hogan RE; Blatt I; Lawson P B; Nguyen H; Clark AM; Anders B; Halvorsen MB;
Epilepsy Behav; 2016 Jun; 59():13-20. PubMed ID: 27084978
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.
Ritter F; Glauser TA; Elterman RD; Wyllie E
Epilepsia; 2000; 41(S1):82-5. PubMed ID: 10768307
[TBL] [Abstract][Full Text] [Related]
15. Topiramate monotherapy for partial onset seizures.
Sachdeo RC; Reife RA; Lim P; Pledger G
Epilepsia; 1997 Mar; 38(3):294-300. PubMed ID: 9070591
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
Faught E
Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group.
Biton V; Montouris GD; Ritter F; Riviello JJ; Reife R; Lim P; Pledger G
Neurology; 1999 Apr; 52(7):1330-7. PubMed ID: 10227614
[TBL] [Abstract][Full Text] [Related]
18. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
[TBL] [Abstract][Full Text] [Related]
20. Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly.
Zhang L; Huang J; Zhuang JH; Huang LQ; Zhao ZX
J Int Med Res; 2011; 39(2):408-15. PubMed ID: 21672344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
